Cargando…
Update on Diabetes Mellitus
Diabetes mellitus is a complex multi-system disorder that may be classified as autoimmune mediated type 1 diabetes, or as insulin resistance associated type 2 diabetes. In type 1 diabetes, there is selective loss of the beta cells within the endocrine islets, as a consequence of T-cell and cytokine...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839330/ https://www.ncbi.nlm.nih.gov/pubmed/15502249 http://dx.doi.org/10.1155/2004/945073 |
_version_ | 1782478423390683136 |
---|---|
author | Korc, Murray |
author_facet | Korc, Murray |
author_sort | Korc, Murray |
collection | PubMed |
description | Diabetes mellitus is a complex multi-system disorder that may be classified as autoimmune mediated type 1 diabetes, or as insulin resistance associated type 2 diabetes. In type 1 diabetes, there is selective loss of the beta cells within the endocrine islets, as a consequence of T-cell and cytokine mediated destruction of these cells, perhaps in conjunction with destruction of the peri-islet Schwann cells. In type 2 diabetes, the etiology of the resistance ranges from post-receptor defects in the insulin signaling pathway to excessive production of adipocyte derived cytokines that antagonize insulin action to mitochondrial defects that interfere with glucose disposal. Proteome based technologies are providing new insights into these defects. |
format | Online Article Text |
id | pubmed-3839330 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | IOS Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-38393302013-12-17 Update on Diabetes Mellitus Korc, Murray Dis Markers Other Diabetes mellitus is a complex multi-system disorder that may be classified as autoimmune mediated type 1 diabetes, or as insulin resistance associated type 2 diabetes. In type 1 diabetes, there is selective loss of the beta cells within the endocrine islets, as a consequence of T-cell and cytokine mediated destruction of these cells, perhaps in conjunction with destruction of the peri-islet Schwann cells. In type 2 diabetes, the etiology of the resistance ranges from post-receptor defects in the insulin signaling pathway to excessive production of adipocyte derived cytokines that antagonize insulin action to mitochondrial defects that interfere with glucose disposal. Proteome based technologies are providing new insights into these defects. IOS Press 2004 2004-10-20 /pmc/articles/PMC3839330/ /pubmed/15502249 http://dx.doi.org/10.1155/2004/945073 Text en Copyright © 2004 Hindawi Publishing Corporation. |
spellingShingle | Other Korc, Murray Update on Diabetes Mellitus |
title | Update on Diabetes Mellitus |
title_full | Update on Diabetes Mellitus |
title_fullStr | Update on Diabetes Mellitus |
title_full_unstemmed | Update on Diabetes Mellitus |
title_short | Update on Diabetes Mellitus |
title_sort | update on diabetes mellitus |
topic | Other |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839330/ https://www.ncbi.nlm.nih.gov/pubmed/15502249 http://dx.doi.org/10.1155/2004/945073 |
work_keys_str_mv | AT korcmurray updateondiabetesmellitus |